老年血液透析病人衰弱与血清瘦素及25-羟维生素D的相关性研究

doi:10.3969/j.issn.1003-9198.2024.06.014

摘要/Abstract

摘要： 目的探究老年血液透析病人血清瘦素及25-羟维生素D[25(OH)D]水平,并分析其与透析病人衰弱的相关性。方法选取2021年4月至2023年4月我院收治的150例老年血液透析病人,依据Fried表型评价病人的衰弱情况,分为非衰弱组(51例),衰弱前期组(74例)和衰弱组(25例)。比较3组一般资料、血清瘦素、25(OH)D及心功能。采用多因素Logistic回归分析老年血液透析病人衰弱的影响因素。结果 3组年龄、糖尿病比例、透析龄、左室舒张末期内径,以及白蛋白、镁、IL-6、瘦素、25(OH)D水平比较,差异均有统计学意义(P<0.01)。多因素有序Logistic回归分析显示,年龄、透析龄、糖尿病、镁、IL-6、白蛋白、瘦素、25(OH)D、左室舒张末期内径是老年血液透析病人衰弱的独立影响因素(P＜0.05)。结论针对白蛋白水平低、瘦素水平高、25(OH)D水平低的老年血液透析病人采取积极干预措施,有利于延缓衰弱的进展。

关键词: 瘦素, 25-羟维生素D, 血液透析, 衰弱, 心功能

Abstract: Objective To investigate the levels of serum leptin and 25-hydroxyvitamin D [25(OH)D], and to analyze their correlation with frailty in the elderly hemodialysis patients. Methods A total of 150 elderly hemodialysis patients admitted to our hospital from April 2021 to April 2023 were enrolled in this study. The patients were divided into non-frailty group (51 cases), pre-frailty group (74 cases) and frailty group (25 cases) according to Fried phenotype. The general data, serum leptin, 25(OH)D and cardiac function of the three groups were compared. Multivariate Logistic regression was used to analyze the influencing factors of frailty in the elderly hemodialysis patients. Results There were significant differences in age, proportion of diabetes mellitus, dialysis age, left ventricular end-diastolic diameter, albumin, magnesium, IL-6, leptin and 25(OH)D levels among the three groups (P<0.01). Multivariate Logistic regression analysis showed that age, dialysis age, diabetes, magnesium, IL-6, albumin, leptin, 25(OH)D and left ventricular end-diastolic diameter were the independent factors of frailty in the elderly hemodialysis patients (P<0.05). Conclusions It is important to intervene the low level of albumin, high level of leptin and low level of 25(OH)D to delay the progression of frailty in the elderly hemodialysis patients.

Key words: leptin, 25-hydroxyvitamin D, hemodialysis, frailty, heart function

中图分类号:

R692

朱蓓, 杭乐佳, 高飞, 袁海川, 赵卫红. 老年血液透析病人衰弱与血清瘦素及25-羟维生素D的相关性研究[J]. 实用老年医学, 2024, 38(6): 603-606.

ZHU Bei, HANG Lejia, GAO Fei, YUAN Haichuan, ZHAO Weihong. Correlation of frailty with serum leptin and 25-hydroxyvitamin D in elderly hemodialysis patients[J]. Practical Geriatrics, 2024, 38(6): 603-606.

参考文献

[1] NASCIMENTO C M, INGLES M, SALVADOR-PASCUAL A, et al. Sarcopenia, frailty and their prevention by exercise[J]. Free Radic Biol Med, 2019, 132:42-49.
[2] PROIETTI M, CESARI M. Frailty: what is it?[J]. Adv Exp Med Biol, 2020, 1216:1-7.
[3] LEE H, LEE E, JANG I Y. Frailty and comprehensive geriatric assessment[J]. J Korean Med Sci, 2020, 35(3):e16.
[4] LEE H J, SON Y J. Prevalence and associated factors of frailty and mortality in patients with end-stage renal disease undergoing hemodialysis: a systematic review and meta-analysis[J]. Int J Environ Res Public Health, 2021, 18(7):3471.
[5] KIMURA H, KALANTAR-ZADEH K, RHEE C M, et al. Polypharmacy and frailty among hemodialysis patients[J]. Nephron, 2021, 145(6):624-632.
[6] SCHULTE-KEMNA L, KÜNZIG M, DALLMEIER D, et al. Frailty in renal diseases[J]. Z Gerontol Geriatr, 2021, 54(7):708-716.
[7] OBRADOVIC M, SUDAR-MILOVANOVIC E, SOSKIC S, et al. Leptin and obesity: role and clinical implication[J]. Front Endocrinol: Lausanne, 2021,12:585887.
[8] BYRN M A, SHEEAN P M. Serum 25(OH)D and cognition: a narrative review of current evidence[J]. Nutrients, 2019, 11(4):729.
[9] FUJIKI S, WATANABE H, OBATA H, et al. Association of adipokines with frailty in heart failure[J]. Acta Biomed, 2021, 92(3):e2021195.
[10] 马爽, 彭楠. 维生素D对衰弱的干预及相关机制的研究[J]. 老年医学与保健, 2022, 28(2):445-449.
[11] DRÜEKE T B, PARFREY P S. Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s)[J]. Kidney Int, 2012, 82(9):952-960.
[12] 韩君,王君俏,谢博钦,等.Fried衰弱表型和FRAIL量表及埃德蒙顿衰弱评估量表在社区高龄老年人衰弱筛查中一致性和适用性的比较研究[J].中国全科医学,2021,24(21):2669-2675.
[13] KHAN K T, HEMATI K, DONOVAN A L. Geriatric physiology and the frailty syndrome[J]. Anesthesiol Clin, 2019, 37(3):453-474.
[14] WILKINSON T J, MIKSZA J, ZACCARDI F, et al. Associations between frailty trajectories and cardiovascular, renal, and mortality outcomes in chronic kidney disease[J]. J Cachexia Sarcopenia Muscle, 2022, 13(5):2426-2435.
[15] ZANOTTO T, MERCER T H, VAN DER LINDEN M L, et al. The relative importance of frailty, physical and cardiovascular function as exercise-modifiable predictors of falls in haemodialysis patients: a prospective cohort study[J]. BMC Nephrol, 2020, 21(1): 99.
[16] 朱亚杰, 陈思婕, 辛霞, 等. 老年维持性血液透析患者衰弱发生情况及影响因素分析[J]. 中华老年医学杂志, 2023, 42(1):35-39.
[17] 解巧丽, 石瑞, 王德光. 老年维持性血液透析患者衰弱发生情况及其影响因素[J]. 中华老年多器官疾病杂志, 2023, 22(5):334-338.
[18] FISCHER A W, CANNON B, NEDERGAARD J. Leptin: is it thermogenic?[J]. Endocr Rev, 2020, 41(2):232-260.
[19] 王娅迪, 刘玲. 透析患者维生素D水平与衰弱表型的相关性分析[J]. 重庆医学, 2019, 48(11):1902-1905.